Late recurrence of choroid plexus carcinoma

Shannon Hart1, Roger Avery2,3, Jane Barron2,4

  • 1Faculty of Medicine, Memorial University of Newfoundland, St. John's, Newfoundland, Canada. sh8062@mun.ca.

Insights

This study highlights a rare case of delayed choroid plexus carcinoma (CPC) recurrence 10 years after initial treatment. Long-term surveillance is crucial for detecting late relapses in pediatric brain tumor patients.

Area of Science:

  • Neuro-oncology
  • Pediatric oncology
  • Rare tumor research

Background:

  • Choroid plexus carcinomas (CPC) are rare, aggressive brain tumors primarily affecting children under two years old.
  • Common symptoms include headaches, vision problems, and signs of increased intracranial pressure.
  • Diagnosis relies on radiological and histological evaluation.

Observation:

  • A 2-month-old male diagnosed with CPC underwent gross total resection (GTR), chemotherapy, and stem cell transplant.
  • The patient later presented with a recurrence of CPC 10 years post-initial diagnosis and treatment.

Findings:

  • Gross total resection (GTR) offers the best survival but prognosis remains poor for CPC.
  • Chemotherapy and radiation efficacy in CPC management are debated, with no standard regimen established.
  • While early recurrence is common, delayed recurrence is exceptionally rare.

Implications:

  • This case underscores the necessity of long-term patient surveillance for choroid plexus carcinomas.
  • It prompts further investigation into the natural history and risk factors for late CPC recurrence.
  • Research should focus on identifying factors predicting late relapse and the role of adjuvant therapies.
Abstract

Related Concept Videos